RELATIONSHIP BETWEEN CD4 LYMPHOCYTE COUNT AND AIDS MORTALITY, 1986-1991

被引:24
作者
MILLS, GD [1 ]
JONES, PD [1 ]
机构
[1] PRINCE HENRY HOSP,DEPT INFECT DIS,SYDNEY,NSW,AUSTRALIA
关键词
AIDS; CD4; LYMPHOCYTE; MORTALITY; SURVIVAL;
D O I
10.1097/00002030-199310000-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To determine the relationship between CD4 lymphocyte count and short-term AIDS mortality, and to determine whether this relationship changed during 1986-1991. Design: A retrospective analysis of CD4 lymphocyte counts in patients dying with AIDS and estimation of median survival in patients with a CD4 count < 50 x 10(6)/l. Methods: Absolute CD4 lymphocyte count in the 6 months before death was available for 178 patients. The terminal CD4 count was compared in five cohorts of patients dying in 12-month periods from July 1986. Kaplan-Meier survival curves were constructed using survival from date of first absolute CD4 count < 50 x 10(6)/l in 271 patients and compared for each yearly cohort. Results: The median terminal CD4 lymphocyte count for all patients was 10 x 106/l. The median terminal CD4 counts for each yearly cohort were: 1986/1987, 100 (n = 13); 1987-1988, 10 (n = 27); 1988-1989, 10 (n = 30); 1989/1990, 20 (n = 59); 1990-1991, 10 (n = 58). There was a significant difference in the terminal CD4 count in the 1986-1987 period compared with all other years combined, but no further changes after 1987-1988. The median survival of all patients from date of first CD4 count < 50 x 10(6)/l was 11.9 months. There was no significant difference in median survival in each yearly cohort. Conclusions: There is a close correlation between CD4 lymphocyte count and short-term mortality in AIDS. Therapeutic advances over the past 5 years are not reflected by changes in CD4 count before death or improved survival in patients with very low CD4 counts.
引用
收藏
页码:1383 / 1386
页数:4
相关论文
共 9 条
[1]   CD4-PERCENT IS THE BEST PREDICTOR OF DEVELOPMENT OF AIDS IN A COHORT OF HIV-INFECTED HOMOSEXUAL MEN [J].
BURCHAM, J ;
MARMOR, M ;
DUBIN, N ;
TINDALL, B ;
COOPER, DA ;
BERRY, G ;
PENNY, R .
AIDS, 1991, 5 (04) :365-372
[2]  
CROWE SM, 1991, J ACQ IMMUN DEF SYND, V4, P770
[3]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[4]   SURROGATE MARKERS IN AIDS - WHERE ARE WE - WHERE ARE WE GOING [J].
LAGAKOS, SW ;
HOTH, DF .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (07) :599-601
[5]  
MACHADO SG, 1990, J ACQ IMMUN DEF SYND, V3, P1065
[6]  
PHILLIPS AN, 1991, LANCET, V337, P389
[7]   IMMUNODEFICIENCY AND THE RISK OF DEATH IN HIV-INFECTION [J].
PHILLIPS, AN ;
ELFORD, J ;
SABIN, C ;
BOFILL, M ;
JANOSSY, G ;
LEE, CA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (19) :2662-2666
[8]   PREDICTORS OF THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME DEVELOPING IN A COHORT OF SEROPOSITIVE HOMOSEXUAL MEN [J].
POLK, BF ;
FOX, R ;
BROOKMEYER, R ;
KANCHANARAKSA, S ;
KASLOW, R ;
VISSCHER, B ;
RINALDO, C ;
PHAIR, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :61-66
[9]   CD4 COUNT AND THE RISK FOR DEATH IN PATIENTS INFECTED WITH HIV RECEIVING ANTIRETROVIRAL THERAPY [J].
YARCHOAN, R ;
VENZON, DJ ;
PLUDA, JM ;
LIETZAU, J ;
WYVILL, KM ;
TSIATIS, AA ;
STEINBERG, SM ;
BRODER, S .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (03) :184-189